Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B

Completed · Phase 3

Conditions studied: Chronic Hepatitis B

In brief

The purpose of this study is to determine the safety and efficacy of Pegasys + placebo + lamivudine versus lamivudine alone in patients with lamivudine versus lamivudine alone in patients with hepatitis B antigen CHB.

Key facts

Study ID

NCT00048945

Run by

Hoffmann-La Roche

People needed

820

Starts

2002-01-01

Expected to finish

2004-10-01

Last updated by the study team

2017-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of hepatitis B
• Not pregnant

You may not qualify if…

• Treatment for hepatitis B in past 6 months
• Other hepatitis infections
• Severe liver disease
• Pregnancy

Where it is running

• Study site — Downey, California, United States
• Study site — Los Angeles, California, United States
• Study site — Pasadena, California, United States
• Study site — San Francisco, California, United States
• Study site — Atlanta, Georgia, United States
• Study site — Honolulu, Hawaii, United States
• Study site — Boston, Massachusetts, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — Lincoln, Nebraska, United States
• Study site — Chapel Hill, North Carolina, United States
• Study site — Cedar Creek, Texas, United States
• Study site — Salt Lake City, Utah, United States
• Study site — Seattle, Washington, United States
• Study site — Concord, Australia
• Study site — Herston, Australia
• Study site — Campinas, Brazil
• Study site — Porto Alegre, Brazil
• Study site — Salvador, Brazil
• Study site — São Paulo, Brazil
• Study site — Calgary, Alberta, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Beijing, China
• Study site — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.